Patent Yard Sign in
Canadian application, no grantCanada

Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications

CA 2493755 A1 · Owner: The Institutes For Pharmaceutical Discovery, Llc · Inventors: Van Zandt, Michael C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed is a compound of the formula (I) its hydrates and/or pharmaceutically acceptable salts, which are useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their preparation.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 28, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 28, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 28, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 28, 2003
GrantedNo grant recorded
Term endedJuly 28, 2023
Patent numberCA 2493755 A1
Classification (IPC)C07D417/06 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedJuly 28, 2003Term endedJuly 28, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.